TransMedics Group, Inc. (TMDX) PS Ratio: 4.48
Is TransMedics Group, Inc.’s P/S ratio high or low?
TransMedics Group, Inc.'s P/S ratio of 4.48 is 72% below its 5-year average of 16.25, near the low end of its 5-year range (3.53–37.54).
As of Saturday, June 20, 2026. 50.21% below its 12-month average of 9.00.
TMDX PS Ratio Chart
TMDX Average PS Ratio Chart
TMDX Current vs Average PS Ratio Chart
TMDX PS Ratio Metrics
PS RATIO
4.48
PS RATIO AVG TTM
9.00
PS RATIO AVG 3Y
10.54
PS RATIO AVG 5Y
16.25
PS RATIO AVG 10Y
N/A
PS RATIO AVG 15Y
N/A
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-50.21%
CURRENT VS 3Y AVG
-57.51%
CURRENT VS 5Y AVG
-72.43%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
TMDX Competitors' PS Ratio
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TransMedics Group, Inc. (TMDX) | $2.72B | 4.48 | 9.00 | 10.54 | 16.25 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.07B | 0.56 | 0.68 | 1.18 | 1.67 |
| 23andMe Holding Co. (ME)vs › | $15.31M | 0.10 | 0.33 | 1.27 | 4.47 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.64B | 2.94 | 3.04 | 3.30 | 4.30 |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.91B | 3.42 | 4.43 | 4.20 | 4.34 |
| Tempus AI, Inc. (TEM)vs › | $8.87B | 6.67 | 10.75 | 11.72 | 11.72 |
| Charles River Laboratories International, Inc. (CRL)vs › | $8.91B | 2.25 | 2.14 | 2.36 | 3.06 |
| Baxter International Inc. (BAX)vs › | $10.27B | 0.90 | 0.99 | 1.30 | 1.79 |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | 0.07 | 0.06 | 0.13 | 0.20 |
| Revvity, Inc. (RVTY)vs › | $11.16B | 3.85 | 3.93 | 4.57 | 4.63 |
P/S vs. its own history
At 4.48, P/S is cheaper than usual, sitting higher than 2% of its 7-year history.
7-year low
3.53
median
16.22
7-year high
50.66
Sales Valuation
P/S Ratio
4.48
Market Cap / Annual Revenue
TransMedics Group, Inc. PS Ratio Formula & Definition
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
TransMedics Group, Inc. PS Ratio FAQ
- What is the P/S ratio for TransMedics Group, Inc. (TMDX)?
- The P/S ratio for TMDX stock is 4.48.
- Is TransMedics Group, Inc.'s P/S ratio high or low?
- TransMedics Group, Inc.'s P/S ratio of 4.48 is 72% below its 5-year average of 16.25, near the low end of its 5-year range (3.53–37.54).
- What is the TTM average P/S ratio for TransMedics Group, Inc. (TMDX)?
- The TTM average P/S ratio for TMDX stock is 9.00.
- What is the 3Y average P/S ratio for TransMedics Group, Inc. (TMDX)?
- The 3Y average P/S ratio for TMDX stock is 10.54.
- What is the 5Y average P/S ratio for TransMedics Group, Inc. (TMDX)?
- The 5Y average P/S ratio for TMDX stock is 16.25.
TransMedics Group, Inc. PS Ratio History
| DATE | PS RATIO |
|---|---|
| 2026-06-18 | 4.48 |
| 2026-06-17 | 4.17 |
| 2026-06-16 | 4.32 |
| 2026-06-15 | 4.30 |
| 2026-06-12 | 4.15 |
| 2026-06-11 | 4.19 |
| 2026-06-10 | 4.26 |
| 2026-06-09 | 4.23 |
| 2026-06-08 | 4.05 |
| 2026-06-05 | 3.95 |
| 2026-06-04 | 4.06 |
| 2026-06-03 | 3.97 |
| 2026-06-02 | 3.90 |
| 2026-06-01 | 3.84 |
| 2026-05-29 | 3.82 |
| 2026-05-28 | 3.86 |
| 2026-05-27 | 3.99 |
| 2026-05-26 | 4.01 |
| 2026-05-22 | 3.92 |
| 2026-05-21 | 3.92 |
| 2026-05-20 | 3.87 |
| 2026-05-19 | 3.76 |
| 2026-05-18 | 3.89 |
| 2026-05-15 | 3.60 |
| 2026-05-14 | 3.53 |
| 2026-05-13 | 3.65 |
| 2026-05-12 | 3.64 |
| 2026-05-11 | 3.66 |
| 2026-05-08 | 3.86 |
| 2026-05-07 | 4.15 |
| 2026-05-06 | 4.15 |
| 2026-05-05 | 5.40 |
| 2026-05-04 | 6.56 |
| 2026-05-01 | 6.76 |
| 2026-04-30 | 6.81 |
| 2026-04-29 | 6.66 |
| 2026-04-28 | 6.84 |
| 2026-04-27 | 7.31 |
| 2026-04-24 | 7.50 |
| 2026-04-23 | 7.65 |
| 2026-04-22 | 7.75 |
| 2026-04-21 | 7.36 |
| 2026-04-20 | 7.65 |
| 2026-04-17 | 7.83 |
| 2026-04-16 | 7.38 |
| 2026-04-15 | 7.85 |
| 2026-04-14 | 7.82 |
| 2026-04-13 | 7.66 |
| 2026-04-10 | 7.71 |
| 2026-04-09 | 7.38 |
| 2026-04-08 | 7.39 |
| 2026-04-07 | 7.25 |
| 2026-04-06 | 7.08 |
| 2026-04-02 | 6.81 |
| 2026-04-01 | 6.79 |
| 2026-03-31 | 6.72 |
| 2026-03-30 | 6.37 |
| 2026-03-27 | 6.70 |
| 2026-03-26 | 6.91 |
| 2026-03-25 | 7.11 |
| 2026-03-24 | 7.36 |
| 2026-03-23 | 7.58 |
| 2026-03-20 | 7.70 |
| 2026-03-19 | 7.69 |
| 2026-03-18 | 7.65 |
| 2026-03-17 | 8.43 |
| 2026-03-16 | 8.43 |
| 2026-03-13 | 8.35 |
| 2026-03-12 | 8.20 |
| 2026-03-11 | 8.72 |
| 2026-03-10 | 8.84 |
| 2026-03-09 | 9.11 |
| 2026-03-06 | 8.76 |
| 2026-03-05 | 9.47 |
| 2026-03-04 | 9.98 |
| 2026-03-03 | 10.00 |
| 2026-03-02 | 9.94 |
| 2026-02-27 | 9.82 |
| 2026-02-26 | 9.10 |
| 2026-02-25 | 8.91 |
| 2026-02-24 | 9.31 |
| 2026-02-23 | 9.69 |
| 2026-02-20 | 9.66 |
| 2026-02-19 | 9.56 |
| 2026-02-18 | 9.75 |
| 2026-02-17 | 9.63 |
| 2026-02-13 | 9.34 |
| 2026-02-12 | 9.25 |
| 2026-02-11 | 9.59 |
| 2026-02-10 | 10.02 |
| 2026-02-09 | 9.81 |
| 2026-02-06 | 9.72 |
| 2026-02-05 | 9.32 |
| 2026-02-04 | 9.38 |
| 2026-02-03 | 9.76 |
| 2026-02-02 | 9.64 |
| 2026-01-30 | 9.64 |
| 2026-01-29 | 10.00 |
| 2026-01-28 | 10.14 |
| 2026-01-27 | 9.96 |
| 2026-01-26 | 10.02 |
| 2026-01-23 | 9.73 |
| 2026-01-22 | 9.94 |
| 2026-01-21 | 9.63 |
| 2026-01-20 | 10.21 |
| 2026-01-16 | 10.32 |
| 2026-01-15 | 10.34 |
| 2026-01-14 | 10.21 |
| 2026-01-13 | 10.27 |
| 2026-01-12 | 9.69 |
| 2026-01-09 | 9.86 |
| 2026-01-08 | 9.90 |
| 2026-01-07 | 9.88 |
| 2026-01-06 | 9.55 |
| 2026-01-05 | 9.09 |
| 2026-01-02 | 8.83 |
| 2025-12-31 | 8.75 |
| 2025-12-30 | 8.77 |
| 2025-12-29 | 8.85 |
| 2025-12-26 | 8.94 |
| 2025-12-24 | 9.14 |
| 2025-12-23 | 9.22 |
| 2025-12-22 | 9.31 |
| 2025-12-19 | 9.19 |
| 2025-12-18 | 8.71 |
| 2025-12-17 | 8.77 |
| 2025-12-16 | 9.00 |
| 2025-12-15 | 8.86 |
| 2025-12-12 | 9.12 |
| 2025-12-11 | 9.18 |
| 2025-12-10 | 9.44 |
| 2025-12-09 | 9.70 |
| 2025-12-08 | 9.83 |
| 2025-12-05 | 9.82 |
| 2025-12-04 | 9.97 |
| 2025-12-03 | 10.08 |
| 2025-12-02 | 10.20 |
| 2025-12-01 | 10.82 |
| 2025-11-28 | 10.53 |
| 2025-11-26 | 10.49 |
| 2025-11-25 | 10.50 |
| 2025-11-24 | 10.09 |
| 2025-11-21 | 9.42 |
| 2025-11-20 | 8.91 |
| 2025-11-19 | 9.60 |
| 2025-11-18 | 8.42 |
| 2025-11-17 | 8.16 |
| 2025-11-14 | 8.27 |
| 2025-11-13 | 8.31 |
| 2025-11-12 | 8.57 |
| 2025-11-11 | 8.79 |
| 2025-11-10 | 8.81 |
| 2025-11-07 | 8.57 |
| 2025-11-06 | 8.99 |
| 2025-11-05 | 8.95 |
| 2025-11-04 | 8.79 |
| 2025-11-03 | 8.97 |
| 2025-10-31 | 9.46 |
| 2025-10-30 | 9.77 |
| 2025-10-29 | 9.66 |
| 2025-10-28 | 9.90 |
| 2025-10-27 | 10.11 |
| 2025-10-24 | 9.96 |
| 2025-10-23 | 9.84 |
| 2025-10-22 | 9.13 |
| 2025-10-21 | 9.17 |
| 2025-10-20 | 9.15 |
| 2025-10-17 | 8.98 |
| 2025-10-16 | 8.83 |
| 2025-10-15 | 8.60 |
| 2025-10-14 | 8.49 |
| 2025-10-13 | 8.53 |
| 2025-10-10 | 8.19 |
| 2025-10-09 | 8.62 |
| 2025-10-08 | 9.01 |
| 2025-10-07 | 8.79 |
| 2025-10-06 | 8.70 |
| 2025-10-03 | 8.83 |
| 2025-10-02 | 8.86 |
| 2025-10-01 | 8.77 |
| 2025-09-30 | 8.57 |
| 2025-09-29 | 8.60 |
| 2025-09-26 | 8.69 |
| 2025-09-25 | 8.70 |
| 2025-09-24 | 8.96 |
| 2025-09-23 | 9.20 |
| 2025-09-22 | 9.55 |
| 2025-09-19 | 9.34 |
| 2025-09-18 | 9.24 |
| 2025-09-17 | 9.15 |
| 2025-09-16 | 9.10 |
| 2025-09-15 | 8.72 |
| 2025-09-12 | 8.75 |
| 2025-09-11 | 8.93 |
| 2025-09-10 | 8.23 |
| 2025-09-09 | 8.27 |
| 2025-09-08 | 8.06 |
| 2025-09-05 | 7.94 |
| 2025-09-04 | 7.94 |
| 2025-09-03 | 8.16 |
| 2025-09-02 | 8.52 |
| 2025-08-29 | 8.78 |
| 2025-08-28 | 8.91 |
| 2025-08-27 | 8.96 |
| 2025-08-26 | 8.79 |
| 2025-08-25 | 8.78 |
| 2025-08-22 | 9.15 |
| 2025-08-21 | 9.07 |
| 2025-08-20 | 9.30 |
| 2025-08-19 | 9.37 |
| 2025-08-18 | 9.59 |
| 2025-08-15 | 9.74 |
| 2025-08-14 | 9.90 |
| 2025-08-13 | 10.08 |
| 2025-08-12 | 10.01 |
| 2025-08-11 | 9.72 |
| 2025-08-08 | 8.74 |
| 2025-08-07 | 8.86 |
| 2025-08-06 | 9.07 |
| 2025-08-05 | 9.60 |
| 2025-08-04 | 9.81 |
| 2025-08-01 | 9.20 |
| 2025-07-31 | 9.08 |
| 2025-07-30 | 8.22 |
| 2025-07-29 | 8.57 |
| 2025-07-28 | 8.60 |
| 2025-07-25 | 8.84 |
| 2025-07-24 | 8.73 |
| 2025-07-23 | 8.99 |
| 2025-07-22 | 8.63 |
| 2025-07-21 | 8.47 |
| 2025-07-18 | 8.98 |
| 2025-07-17 | 9.20 |
| 2025-07-16 | 9.26 |
| 2025-07-15 | 9.46 |
| 2025-07-14 | 9.56 |
| 2025-07-11 | 9.19 |
| 2025-07-10 | 10.20 |
| 2025-07-09 | 10.33 |
| 2025-07-08 | 10.20 |
| 2025-07-07 | 10.23 |
| 2025-07-03 | 10.56 |
| 2025-07-02 | 10.44 |
| 2025-07-01 | 10.64 |
| 2025-06-30 | 10.96 |
| 2025-06-27 | 10.75 |
| 2025-06-26 | 10.63 |
| 2025-06-25 | 10.51 |
| 2025-06-24 | 10.84 |
| 2025-06-23 | 10.43 |
| 2025-06-20 | 10.10 |
| 2025-06-18 | 10.14 |
| 2025-06-17 | 11.13 |
| 2025-06-16 | 11.61 |
| 2025-06-13 | 11.68 |
| 2025-06-12 | 11.69 |
| 2025-06-11 | 11.68 |
| 2025-06-10 | 11.52 |
| 2025-06-09 | 11.40 |
| 2025-06-06 | 11.37 |
Showing the most recent 260 of 1,793 data points. The chart above shows the full history.
Related Metrics
About TransMedics Group, Inc.
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body. The OCS suite encompasses specialized modules: OCS LUNG, which facilitates the preservation of standard criteria donor lungs for double-lung transplants; OCS Heart, designed for the extracorporeal perfusion and maintenance of donor hearts; and OCS Liver, dedicated to the preservation of donor livers. Founded in 1998, TransMedics is headquartered in Andover, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Waleed H. Hassanein